Health care professionals may find information about FDA-approved indications for KEYTRUDA® (pembrolizumab) along with KEYNOTE clinical trials and treatment guidelines.
Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv), an antibody-drug conjugate, for the treatment of adult patients with locally adv...
You are encouraged to report negative side effects of prescription drugs to the FDA. Visitwww.fda.gov/medwatchor call1-800-FDA-1088. Please read the accompanyingMedication Guidefor KEYTRUDA and discuss it with your doctor. The physicianPrescribing Informationalso is available....
FDA-Approved Indications KEYTRUDA is a prescription medicine used to treat a kind of uterine cancer called advanced endometrial carcinoma. KEYTRUDA may be used with the chemotherapy medicines carboplatin and paclitaxel, and then KEYTRUDA may be used alone, in adults: when your cancer has spread (adv...
KEYTRUDA, in combination with gemcitabine and cisplatin, is indicated for the treatment of patients with locally advanced unresectable or metastatic biliary tract carcinoma (BTC). See additional selected KEYTRUDA indications in the U....
Indications forKEYTRUDA® (pembrolizumab)+LENVIMA® (lenvatinib) Advanced Renal Cell Carcinoma KEYTRUDA, in combination with LENVIMA, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC). Advanced Endometrial Carcinoma ...
今年6月,默沙东召开5年来首个投资者日会议表示,预计在未来5年,Keytruda批准的适应症将增加一倍以上。(生物谷Bioon.com) 原文出处:FDA Accepts Merck’s Supplemental Biologics License Applications for KEYTRUDA® (pembrolizumab) Six-Week Dosing Schedule for Melanoma and Multiple Other Indications...
FDA approval history for Keytruda (pembrolizumab) used to treat Melanoma, Metastatic, Non Small Cell Lung Cancer, Head and Neck Cancer, Hodgkin's Lymphoma, Urothelial Carcinoma, Gastric Cancer, Cervical Cancer, Hepatocellular Carcinoma, Merkel Cell Carci
FDA-Approved Indications KEYTRUDA is a prescription medicine used to treat a kind of skin cancer called melanoma. KEYTRUDA may be used: when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or in adults and children 12 years of age and older with stage IIB, stag...
In the U.S., KEYTRUDA has two additional approved indications in cervical cancer: in combination with chemotherapy, with or without bevacizumab, for the treatment of patients with persistent, recurrent, or metastatic cervical cancer wh...